According to @mcuban, scale in healthcare enables regulatory capture as large firms can buy enough companies and generate sufficient profits to influence the rules. Source: @mcuban on X, Nov 28, 2025. He adds that markets need efficiency and asserts healthcare markets have zero efficiency. Source: @mcuban on X, Nov 28, 2025. For traders, his comments flag headline and policy-risk sensitivity for large, consolidation-driven healthcare equities (insurers, PBMs, hospital roll-ups), where perceived regulatory capture could act as a negative sentiment catalyst in valuation screens and positioning. Source: @mcuban on X, Nov 28, 2025. Active strategies may focus on relative strength between mega-cap acquirers and smaller providers during antitrust, pricing, or M&A newsflow that aligns with this critique. Source: @mcuban on X, Nov 28, 2025.

According to @nic__carter, prominent crypto firms are engaging in regulatory capture to eliminate competition, a tactic reminiscent of those used by SBF. This practice could potentially influence market dynamics by limiting competition, leading to less innovation and higher barriers for new entrants. Traders should be aware of how regulatory maneuvers can impact market conditions and the competitive landscape.